Skip to main content
Journal cover image

Relationship between binding affinity, retention and sensitivity of human rhabdomyosarcoma xenografts to Vinca alkaloids.

Publication ,  Journal Article
Houghton, JA; Williams, LG; Dodge, RK; George, SL; Hazelton, BJ; Houghton, PJ
Published in: Biochem Pharmacol
January 1, 1987

Xenografts of human rhabdomyosarcoma (RMS) have been derived that differ in their degree of sensitivity to Vinca alkaloids. Lines Rh12 and Rh18 demonstrated, respectively, high and moderate sensitivity to vincristine (VCR), but showed little responsiveness to vinblastine (VLB) in vivo. Rh18/VCR-3, a subline of Rh18 selected for resistance to VCR under in situ conditions, was insensitive to further challenge with VCR. Resistance was associated with elimination of the agent in a biphasic manner, whereas sensitivity to VCR corresponded to very prolonged drug retention in sensitive neoplastic tissues. The initial half-times for drug retention in tumors in vivo (t1/2 alpha) correlated with the degree of sensitivity of tumors to Vinca alkaloids, decreasing t1/2 alpha being associated with decreased sensitivity. A single binding species was observed when membrane-free supernatant fractions were incubated at 37 degrees for 15 min with 10.4 nM [3H]VCR and analyzed by gel filtration HPLC. The protein eluted with a retention time of 57 min and corresponded to a molecular weight (Mr) of approximately 113,000 daltons, agreeing very closely with the Mr of dimeric tubulin (approximately equal to 110,000 daltons). Two fractions were collected and eluted on a one-dimensional denaturing gel. Proteins were transferred subsequently to nitrocellulose and probed with an 125I-labeled monoclonal antibody specific for beta-tubulins. Only the fraction containing bound [3H]VCR contained tubulin. Estimates for the dissociation constants (Kd) for the binding affinity of VCR and VLB in crude, membrane-free supernatant fractions from RMS xenografts were obtained by computer curve fitting using a mathematical binding model. Data fitted a two-site binding model, with Kd values for the high-affinity site ranging from 61 to 160 nM, and for the low-affinity site, from 42 to 94 microM. At physiologically achievable drug concentrations, the relationship between binding affinity, drug retention and tumor sensitivity was examined further. A close relationship was apparent between the Kd values for VCR in Rh12, Rh18 and Rh18/VCR-3 tumor supernatant fractions and VLB in Rh12 preparations, and t1/2 alpha values for drug retention. Prolonged drug retention correlated with a low binding constant. As t1/2 alpha decreased, binding affinity also decreased, as demonstrated by an increase in the Kd value. Consequently, the tightness of drug binding in tumors also correlated with the degree of sensitivity of the xenografts to Vinca alkaloids.(ABSTRACT TRUNCATED AT 400 WORDS)

Duke Scholars

Published In

Biochem Pharmacol

DOI

ISSN

0006-2952

Publication Date

January 1, 1987

Volume

36

Issue

1

Start / End Page

81 / 88

Location

England

Related Subject Headings

  • Vinca Alkaloids
  • Transplantation, Heterologous
  • Rhabdomyosarcoma
  • Pharmacology & Pharmacy
  • Neoplasm Transplantation
  • Mice, Inbred CBA
  • Mice
  • Immunosorbent Techniques
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Houghton, J. A., Williams, L. G., Dodge, R. K., George, S. L., Hazelton, B. J., & Houghton, P. J. (1987). Relationship between binding affinity, retention and sensitivity of human rhabdomyosarcoma xenografts to Vinca alkaloids. Biochem Pharmacol, 36(1), 81–88. https://doi.org/10.1016/0006-2952(87)90384-4
Houghton, J. A., L. G. Williams, R. K. Dodge, S. L. George, B. J. Hazelton, and P. J. Houghton. “Relationship between binding affinity, retention and sensitivity of human rhabdomyosarcoma xenografts to Vinca alkaloids.Biochem Pharmacol 36, no. 1 (January 1, 1987): 81–88. https://doi.org/10.1016/0006-2952(87)90384-4.
Houghton JA, Williams LG, Dodge RK, George SL, Hazelton BJ, Houghton PJ. Relationship between binding affinity, retention and sensitivity of human rhabdomyosarcoma xenografts to Vinca alkaloids. Biochem Pharmacol. 1987 Jan 1;36(1):81–8.
Houghton, J. A., et al. “Relationship between binding affinity, retention and sensitivity of human rhabdomyosarcoma xenografts to Vinca alkaloids.Biochem Pharmacol, vol. 36, no. 1, Jan. 1987, pp. 81–88. Pubmed, doi:10.1016/0006-2952(87)90384-4.
Houghton JA, Williams LG, Dodge RK, George SL, Hazelton BJ, Houghton PJ. Relationship between binding affinity, retention and sensitivity of human rhabdomyosarcoma xenografts to Vinca alkaloids. Biochem Pharmacol. 1987 Jan 1;36(1):81–88.
Journal cover image

Published In

Biochem Pharmacol

DOI

ISSN

0006-2952

Publication Date

January 1, 1987

Volume

36

Issue

1

Start / End Page

81 / 88

Location

England

Related Subject Headings

  • Vinca Alkaloids
  • Transplantation, Heterologous
  • Rhabdomyosarcoma
  • Pharmacology & Pharmacy
  • Neoplasm Transplantation
  • Mice, Inbred CBA
  • Mice
  • Immunosorbent Techniques
  • Humans
  • Female